It is worth noting that many moons ago GTC had programs with Centocor (now JNJ) and Abbott to make Remicade and Humira respectivly, both of which progressed to having animals which successfully produced the drugs.
Noted. Do you have any further information on why these successful mAb trials never eventuated into anything of substance for GTC? no clinical trials, no commercial supply arrangements? What stopped J&J and Abbott from proceeding? Thanks.
Market Data 
Markets 
AI
